GLPBio

Pogostone

Catalog No.: GC45550Purity:>98.00%
يتم عزل Pogostone من الباتشولي مع أنشطة مضادة للبكتيريا ومضادة للسرطان

المنتجات مخصصة للاستخدام البحثي فقط، وليست للاستخدام البشري. نحن لا نبيع للمرضى.


Pogostone
Cas No.: 23800-56-8
10mM (in 1mL DMSO)In Stock
$31.00
1
5mgIn Stock
$28.00
1
10mgIn Stock
$48.00
1
25mgIn Stock
$100.00
1
50mgIn Stock
$168.00
1
100mgIn Stock
$288.00
1

المراجع (Citations)

لا تتوفر حاليًا مراجع لهذا المنتج. فيما يلي مجموعة مختارة من المنشورات التي تستشهد بمنتجات GlpBio.
  • Nature cover
    Nature
    641, 529–536 (2025)
  • Nature cover
    Nature
    628, 630–638 (2024)
  • Nature cover
    Nature
    632, 686–694 (2024)
  • Nature cover
    Nature
    618, 1017–1023 (2023)
  • Nature cover
    Nature
    610, 366–372 (2022)
  • Cell cover
    Cell
    187(9):2288-2304 (2024)
  • Cell cover
    Cell
    183(7):1867-1883 (2020)
  • Science cover
    Science
    388(6745) (2025)
  • Science cover
    Science
    387(6739) (2025)
  • Science cover
    Science
    387(6734) (2025)
  • Cell Research cover
    Cell Research
    35, 97–116 (2025)
  • Cell Research cover
    Cell Research
    34, 683–706 (2024)
  • Cell Research cover
    Cell Research
    33, 273–287 (2023)
  • Cell Research cover
    Cell Research
    33, 546–561 (2023)
  • Cell Research cover
    Cell Research
    33, 904–922 (2023)
  • Cell Research cover
    Cell Research
    31, 1291–1307 (2021)

الوصف (Description)

Pogostone, a pyranone, is a major constituent of the essential oil preparation called Pogostemonis Herba [1]. Pogostone can alleviate experimental colitis by inhibiting the activity of myeloperoxidase and suppressing the secretion of various inflammatory cytokines, including IFN-γ, IL-12p70, IL-17A and IL-10[2]. Pogostone has been widely used to kill pests and inhibit the development of larvae[3].

In vitro, Pogostone significantly inhibited the viability of HCT116 cells, SW620 cells and MV4-11 cells after 72 hours of treatment, with IC50 values of 18.7µg/ml, 21.39µg/ml and 22.62µg/ml, respectively[4]. Treatment with 90μg/ml Pogostone for 24 hours significantly induced apoptosis in OVCAR-3 cells and promoted the increase in the expression of CASP3 protein[5]. Treatment with 40μM Pogostone for 24 hours significantly reduced the levels of TNF-α-induced inflammatory cytokines in A549 cells, and decreased oxidative stress and cell death[6].

In vivo, Pogostone treatment at a single intravenous dose of 20mg/kg for 6 hours can protect mice from lipopolysaccharide (LPS)-mediated death and alleviate the organ damage induced by LPS in mice[7]. Intraperitoneal injection of Pogostone (25mg/kg/day) for 4 weeks can inhibit bone loss in MDA-MB-231 breast cancer mice and alleviate the damage of bone trabecular structure[8].

References:
[1] Chen J, Liu L, Wang Y, et al. Characterization of a cytosolic acyl-activating enzyme catalyzing the formation of 4-methylvaleryl-CoA for pogostone biosynthesis in Pogostemon cablin[J]. Plant and Cell Physiology, 2021, 62(10): 1556-1571.
[2] Su J, Li C, Yu X, et al. Protective effect of pogostone on 2, 4, 6-trinitrobenzenesulfonic acid-induced experimental colitis via inhibition of T helper cell[J]. Frontiers in Pharmacology, 2017, 8: 829.
[3] Huang S H, Xian J D, Kong S Z, et al. Insecticidal activity of pogostone against Spodoptera litura and Spodoptera exigua (Lepidoptera: Noctuidae)[J]. Pest management science, 2014, 70(3): 510-516.
[4] Cao Z X, Yang Y T, Yu S, et al. Pogostone induces autophagy and apoptosis involving PI3K/Akt/mTOR axis in human colorectal carcinoma HCT116 cells[J]. Journal of ethnopharmacology, 2017, 202: 20-27.
[5] Homayoun M, Sajedi N, Soleimani M. In vitro evaluation of the pogostone effects on the expression of PTEN and DACT1 tumor suppressor genes, cell cycle, and apoptosis in ovarian cancer cell line[J]. Research in pharmaceutical sciences, 2022, 17(2): 164-175.
[6] Yang H M, Zhuo J Y, Sun C Y, et al. Pogostone attenuates TNF-α-induced injury in A549 cells via inhibiting NF-κB and activating Nrf2 pathways[J]. International immunopharmacology, 2018, 62: 15-22.
[7] Li Y C, Xian Y F, Su Z R, et al. Pogostone suppresses proinflammatory mediator production and protects against endotoxic shock in mice[J]. Journal of ethnopharmacology, 2014, 157: 212-221.
[8] Zheng T, Lin Z, Jiang G, et al. Pogostone attenuates osteolysis in breast cancer by inhibiting the NF-kB and JNK signaling pathways of osteoclast[J]. Life Sciences, 2023, 328: 121611.

البروتوكول (Protocol)

Cell experiment [1]:

Cell lines

HCT116 cells

Preparation Method

HCT116 cells were grown in DMEM media supplemented with 10% fetal bovine serum in 5% CO2 at 37°C. The exponentially growing HCT116 cells were seeded into 96-well microplates for 24h. Afterwards, an equal volume of medium containing various concentrations of Pogostone (0, 5, 10, 25, 50, and 100µg/ml) were added to each well. At the end of the incubation period (72h at 37°C), cell viability was analyzed.

Reaction Conditions

0, 5, 10, 25, 50, and 100µg/ml; 72h

Applications

Pogostone treatment significantly reduced the cell viability of HCT116 cells in a dose-dependent manner.
Animal experiment [2]:

Animal models

Female BALB/c nu/nu mice

Preparation Method

Female BALB/c nu/nu mice (6 weeks old) were kept in temperature-controlled (21°C-25°C) and humidity-maintained (40%-70%) rooms with a 12-h light/dark cycle. Water and food were provided freely. By anterolateral inoculation, MDA-MB-231 cells were injected into 16 mice on the right tibial plateau. Then, mice were randomly allocated to two groups with regular intraperitoneal injection: the Pogostone-treated group with Pogostone at 25mg/kg/day and the vehicle group with an equivalent amount of PBS. All mice were administered intraperitoneally for 4 weeks. Remove the right tibias from the euthanized mice for subsequent micro-CT scanning.

Dosage form

25mg/kg/day for 4 weeks; i.p.

Applications

Pogostone treatment reduced bone loss in MDA-MB-231 breast cancer mice and alleviated the damage of bone trabecular structure.

References:
[1] Cao Z X, Yang Y T, Yu S, et al. Pogostone induces autophagy and apoptosis involving PI3K/Akt/mTOR axis in human colorectal carcinoma HCT116 cells[J]. Journal of ethnopharmacology, 2017, 202: 20-27.
[2] Zheng T, Lin Z, Jiang G, et al. Pogostone attenuates osteolysis in breast cancer by inhibiting the NF-kB and JNK signaling pathways of osteoclast[J]. Life Sciences, 2023, 328: 121611.

وثائق المنتج (Product Documents)

Purity:>98.00%Appearance:A solid

الخصائص الكيميائية (Chemical Properties)

رقم CAS
23800-56-8
SMILES
CC(C)CCC(C1=C(O)C=C(C)OC1=O)=O
الصيغة الجزيئية
C12H16O4
الوزن الجزيئي
224.3
الذوبانية
DMF: 1.6mg/mL,DMSO: 3mg/mL,Ethanol: 3mg/mL,Ethanol:PBS (pH 7.2) (1:5): 0.16mg/mL
التخزين
4°C, protect from light
إرشادات عامة
اختر مذيبًا مناسبًا وفقًا لبيانات ذوبانية المنتج. بعد التحضير، قسّم المحلول المخزون إلى أجزاء لتجنب دورات التجميد والذوبان المتكررة.
استخدم المحاليل المخزونة خلال 6 أشهر عند حفظها في -80°C، أو خلال شهر واحد عند حفظها في -20°C.
لتحسين الذوبانية، سخّن الأنبوب إلى 37°C وعرّضه للموجات فوق الصوتية لمدة مناسبة.
شروط الشحن
تُشحن عينات التقييم مع عبوات تبريد. وتُشحن الأحجام الأخرى المتاحة في درجة حرارة الغرفة، أو مع عبوات تبريد عند الطلب.

الحاسبات (Calculators)المولارية / التخفيف / الوزن الجزيئي / تحويل الوحدات / تركيبة داخل الجسم الحي / الذوبانية

g/mol

Reviews

Review for Pogostone

Rating: 5
  • 5 Star100%
  • 4 Star0%
  • 3 Star0%
  • 2 Star0%
  • 1 Star0%